Paul Tudor Jones Cv Rx, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 75,885 shares of CVRX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,885
Previous 63,482
19.54%
Holding current value
$1.04 Million
Previous $559,000
71.91%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$56.5 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$27.9 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$12.7 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$12.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$12.1 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $283M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...